Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis

Project description

New model for non-invasive breast cancer diagnosis

Breast cancer patients often undergo biopsies, which may lack precision, are costly, painful, and require time-consuming analysis. Ultrasound B-mode imaging is a low-cost, non-invasive alternative. Researchers at the Institute of Physics for Medicine in Paris have developed quantitative ultrasound techniques to measure tissue stiffness, fibre organisation, and vascular mapping (key factors in understanding tumour development). The ERC-funded MUSCAD project aims to leverage machine learning to analyse multiparametric maps generated by innovative ultrafast ultrasound techniques for non-invasive breast cancer diagnosis. The project will integrate these techniques into a unified framework, compile a large clinical dataset, and develop a predictive malignancy model to assess tumour characteristics. This could enable virtual biopsies, improving diagnostic accuracy and enhancing patient comfort.

Objective

Tumour development follows a diversity of complementary biological pathways, including the modification of the tissue structure and vascularization, which are not currently captured by imaging techniques in the clinic. Breast cancer patients undergo a series of imaging sessions using complementary modalities, including ionizing mammographies. In many cases, this imaging is not precise enough for a diagnosis, so that tissue samples in the form of biopsies are used to further characterize the tumour and determine the appropriate treatment. Beyond the pain and stress associated with biopsies, this complex process is costly and time consuming, and delays the time to diagnosis.
Ultrasound B-mode imaging is largely used in the diagnostic process of breast cancer, in part because it is low cost, portable and largely available, as well as non-ionizing and non-invasive. Our laboratory, Institute Physics for Medicine Paris has recently developed several quantitative techniques allowing for the measurement of tissue stiffness, fiber organization, and vascular mapping, all relevant to tumour development. In this project, I propose a new approach to diagnosing breast cancer non-invasively by applying machine learning analysis to rich volumetric multiparametric maps of complementary tumour aspects, obtained using these innovative ultrafast ultrasound techniques. The project will tackle the technological challenge of integrating these techniques into a common acquisition and analysis framework, and include the collection of a large clinical dataset and the development and validation of a predictive malignancy model informing on tumour characteristics for the diagnosis. This approach will open the door to fully virtual biopsies, impacting society on a large scale in terms of cost, diagnostic efficacy, and patient comfort.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-STG

See all projects funded under this call

Host institution

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 1 499 498,00
Address
RUE DE TOLBIAC 101
75654 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
€ 1 499 498,00

Beneficiaries (1)